Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

por Butelman, Eduardo R., Kreek, Mary Jeanne
Publicado 2015

Corrigendum: Salvinorin A, a kappa-opioid receptor agonist hallucinogen: pharmacology and potential template for novel pharmacotherapeutic agents in neuropsychiatric disorders

por Butelman, Eduardo R., Kreek, Mary Jeanne
Publicado 2015

Gender-specific association of functional prodynorphin 68 bp repeats with cannabis exposure in an African American cohort

por Yuferov, Vadim, Butelman, Eduardo R, Kreek, Mary Jeanne
Publicado 2018

Rapid-Onset Anti-Stress Effects of a Kappa-Opioid Receptor Antagonist, LY2795050, Against Immobility in an Open Space Swim Paradigm in Male and Female Mice

por Baynard, Caroline, Prisinzano, Thomas E., Butelman, Eduardo R.
Publicado 2021

Neurocognitive and neuroinflammatory correlates of PDYN and OPRK1 mRNA expression in the anterior cingulate in postmortem brain of HIV-infected subjects

por Yuferov, Vadim, Butelman, Eduardo R, Ho, Ann, Morgello, Susan, Kreek, Mary Jeanne
Publicado 2014

Repeated Administration of Opra Kappa (LY2456302), a Novel, Short-Acting, Selective KOP-r Antagonist, in Persons with and without Cocaine Dependence

por Reed, Brian, Butelman, Eduardo R, Fry, Rebecca S, Kimani, Rachel, Kreek, Mary Jeanne
Publicado 2018

Has the United States Reached a Plateau in Overdoses Caused by Synthetic Opioids After the Onset of the COVID-19 Pandemic? Examination of Centers for Disease Control and Prevention...

por Brown, Kate G., Chen, Carina Y., Dong, Deanna, Lake, Kimberly J., Butelman, Eduardo R.
Publicado 2022

Non-medical Cannabis Self-Exposure as a Dimensional Predictor of Opioid Dependence Diagnosis: A Propensity Score Matched Analysis

por Butelman, Eduardo R., Maremmani, Angelo G. I., Bacciardi, Silvia, Chen, Carina Y., Correa da Rosa, Joel, Kreek, Mary Jeanne
Publicado 2018

Overdose mortality rates for opioids or stimulants are higher in males than females, controlling for rates of drug misuse: State-level data

por Butelman, Eduardo R., Huang, Yuefeng, Epstein, David H., Shaham, Yavin, Goldstein, Rita Z., Volkow, Nora D., Alia-Klein, Nelly
Publicado 2023

Association of Serotonin Transporter (SERT) Polymorphisms with Opioid Dependence and Dimensional Aspects of Cocaine Use in a Caucasian Cohort of Opioid Users

por Yuferov, Vadim, Butelman, Eduardo R, Randesi, Matthew, van den Brink, Wim, Blanken, Peter, van Ree, Jan M, Kreek, Mary Jeanne
Publicado 2021

Characterization of Pyrrolidinyl-hexahydro-pyranopiperazines as a Novel Kappa Opioid Receptor Agonist Scaffold

por Reed, Brian, Miller, Michael, Michino, Mayako, Butelman, Eduardo R., Ben-Ezra, Ariel, Pikus, Philip, Morochnik, Michelle, Kim, Yuli, Ripka, Amy, Vacca, Joseph, Kreek, Mary Jeanne
Publicado 2022

The Kappa Opioid Receptor Agonist 16-Bromo Salvinorin A Has Anti-Cocaine Effects without Significant Effects on Locomotion, Food Reward, Learning and Memory, or Anxiety and Depress...

por van de Wetering, Ross, Ewald, Amy, Welsh, Susan, Kornberger, Lindsay, Williamson, Samuel E., McElroy, Bryan D., Butelman, Eduardo R., Prisinzano, Thomas E., Kivell, Bronwyn M.
Publicado 2023

Design, synthesis, and preliminary evaluation of a potential synthetic opioid rescue agent

por Hedrick, Sidnee L., Luo, Dan, Kaska, Sophia, Niloy, Kumar Kulldeep, Jackson, Karen, Sarma, Rupam, Horn, Jamie, Baynard, Caroline, Leggas, Markos, Butelman, Eduardo R., Kreek, Mary Jeanne, Prisinzano, Thomas E.
Publicado 2021